2024
Screening for Hepatocellular Carcinoma and Survival in Patients With Cirrhosis After Hepatitis C Virus Cure
Mezzacappa C, Kim N, Vutien P, Kaplan D, Ioannou G, Taddei T. Screening for Hepatocellular Carcinoma and Survival in Patients With Cirrhosis After Hepatitis C Virus Cure. JAMA Network Open 2024, 7: e2420963. PMID: 38985470, PMCID: PMC11238019, DOI: 10.1001/jamanetworkopen.2024.20963.Peer-Reviewed Original ResearchConceptsHepatitis C virus cureHepatitis C virusAssociated with improved overall survivalHepatocellular carcinoma diagnosisEarly-stage hepatocellular carcinomaImproved overall survivalOverall survivalHepatocellular carcinomaFollow-upHCC screeningCurative treatmentCumulative incidence of hepatocellular carcinomaDirect-acting antiviral (DAA) therapyCohort studyVeterans Affairs health care systemIncidence of hepatocellular carcinomaRisk of hepatocellular carcinomaCohort study of personsHepatitis C virus cirrhosisDiagnosis of hepatocellular carcinomaLikelihood of curative treatmentYears of follow-upHealth care systemHepatocellular carcinoma screeningHCV-related cirrhosis
2022
Effect of a cancer tracking system on timeliness of liver cancer care at a Veteran's Hospital.
Ivatorov A, Mezzacappa C, Taddei T. Effect of a cancer tracking system on timeliness of liver cancer care at a Veteran's Hospital. Journal Of Clinical Oncology 2022, 40: 406-406. DOI: 10.1200/jco.2022.40.4_suppl.406.Peer-Reviewed Original ResearchHepatocellular carcinomaSuspicious imagingBCLC stageHCC diagnosisAdjusted mean reductionEarly BCLC stagesLiver cancer carePost-intervention cohortPre-intervention cohortSpecialty care appointmentsPost-intervention groupVeterans Affairs hospitalComplex care coordinationPre-intervention periodPost-intervention periodCare delaysPatient ageCare appointmentsCare preCancer careCare coordinationHCC screeningMean changeVeterans HospitalMean reduction